Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies (Q38379405)
Jump to navigation
Jump to search
scientific article published on June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies |
scientific article published on June 2009 |
Statements
1 reference
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies (English)
1 reference
Karen A Tourian
1 reference
S Krishna Padmanabhan
1 reference
James Groark
1 reference
Claudine Brisard
1 reference
Deborah Farrington
1 reference
1 June 2009
1 reference
1 reference
Identifiers
1 reference